NMT EasyFit Sensor and Cable

NCT07394140 | Not Yet Recruiting FDA Device

• 1 other identifier: SA-000175
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this clinical study is to collect and assess feedback from clinical users regarding the functionality and device use and collection of raw parameter date from the NMT Sensor and NMT Cable.

Conditions

Neuromuscular Monitoring After Administration of Neuromuscular Blocking Agents in Different Types of Surgery; Neuromuscular Blockade Monitoring

Outcome Measures

Primary Outcomes (1)

• Collection of End User Feedback Surveys

  Collection of end user feedback surveys on the functionality and clinical use of the NMT Sensor and Cable during standard of care surgical procedure (minimum of 1 hour and maximum of 24 hours).

  Up to 24 hours

Secondary Outcomes (2)

• Collection of raw parameter data from NMT Sensor and Cable

  Up to 24 hours

• Incidence of Safety Events

  4 months.

Study Arms (1)

All Subjects

EXPERIMENTAL

Placement of NMT Sensor

Device: NMT Technology

Interventions

NMT Technology DEVICE

Collection and assessment of non-invasive electrical stimuli from the NMT measurement placed on the patient's hand and forearm to measure the level of neuromuscular blocking agents during standard of care surgical procedures.

All Subjects

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Study subject (male or female) is age 18 years or older (≥18 years).
• Study subject must have the ability to understand and provide written informed consent.
• Study subject is undergoing a clinically indicated procedure requiring the use of paralytic medication.
• Study subject will have the primary NMT monitoring conducted using an NMT ElectroSensor on the hand/forearm.

You may not qualify if:

• Are known to be pregnant.
• Are breastfeeding.
• Suffering from an infection(s) that requires isolation.
• Deformity, scar tissue, tattoos, or other characteristics at the sensor application area that could interfere (e.g., nerve damage) with the completion of the study procedure or identify a study subject.
• Subjects requiring rapid sequence induction
• Subjects expected to be at risk from participation for any reason, such as those with known allergy or sensitivity to adhesive materials that may be used in the study.
• Direct employees or contractors of GE HealthCare, or any company that makes NMT monitoring devices (sensors, cables, modules).
• NMT ElectroSensor placed on the foot/ankle

Sponsors & Collaborators

• GE Healthcare: lead
• Loma Linda University: collaborator

Study Sites (1)

Loma Linda University Health

Loma Linda, California, 92354, United States

Location

Central Study Contacts

Melissa McCabe, MD

CONTACT

909-558-4475; mmccabe@llu.edu

Morgan Blazy

CONTACT

909-558-4256; Mblazy@llu.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: DEVICE FEASIBILITY
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 2, 2026
• First Posted: February 6, 2026
• Study Start: February 1, 2026
• Primary Completion (Estimated): May 31, 2026
• Study Completion (Estimated): December 31, 2026
• Last Updated: February 6, 2026

Record last verified: 2026-02

Locations

US (1)